Staar Surgical [STAA] vs Becton, Dickinson [BDX] Detailed Stock Comparison
Staar Surgical
NASDAQ
Loading...
Becton, Dickinson
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Staar Surgical wins in 5 metrics, Becton, Dickinson wins in 13 metrics, with 0 ties. Becton, Dickinson appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Staar Surgical | Becton, Dickinson | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 49.73 | 35.89 | Becton, Dickinson |
| Price-to-Book Ratio | 4.09 | 2.21 | Becton, Dickinson |
| Debt-to-Equity Ratio | 12.04 | 75.93 | Staar Surgical |
| PEG Ratio | -0.15 | 1.88 | Staar Surgical |
| EV/EBITDA | -16.94 | 12.63 | Staar Surgical |
| Profit Margin (TTM) | -42.45% | 7.41% | Becton, Dickinson |
| Operating Margin (TTM) | -55.63% | 17.81% | Becton, Dickinson |
| EBITDA Margin (TTM) | N/A | 17.81% | N/A |
| Return on Equity | -25.55% | 6.18% | Becton, Dickinson |
| Return on Assets (TTM) | -10.71% | 3.96% | Becton, Dickinson |
| Free Cash Flow (TTM) | $-7.67M | $3.07B | Becton, Dickinson |
| Dividend Yield | N/A | 1.80% | N/A |
| 1-Year Return | -16.53% | -16.82% | Staar Surgical |
| Price-to-Sales Ratio (TTM) | 6.17 | 2.63 | Becton, Dickinson |
| Enterprise Value | $1.24B | $74.75B | Becton, Dickinson |
| EV/Revenue Ratio | 5.51 | 3.50 | Becton, Dickinson |
| Gross Profit Margin (TTM) | 74.00% | 47.81% | Staar Surgical |
| Revenue per Share (TTM) | $5 | $74 | Becton, Dickinson |
| Earnings per Share (Diluted) | $-1.93 | $5.47 | Becton, Dickinson |
| Beta (Stock Volatility) | 0.62 | 0.22 | Becton, Dickinson |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Staar Surgical vs Becton, Dickinson Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Staar Surgical | 0.29% | -2.80% | 56.36% | 50.51% | 64.61% | 15.23% |
| Becton, Dickinson | 1.54% | 0.84% | 12.15% | 13.57% | -13.54% | -13.18% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Staar Surgical | -16.53% | -71.80% | -39.17% | 243.26% | 461.01% | 531.14% |
| Becton, Dickinson | -16.82% | -22.50% | -16.99% | 41.11% | 189.08% | 284.34% |
Performance & Financial Health Analysis: Staar Surgical vs Becton, Dickinson
| Metric | STAA | BDX |
|---|---|---|
| Market Information | ||
| Market Cap | $1.39B | $56.27B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 2,070,420 | 2,951,116 |
| 90 Day Avg. Volume | 2,461,810 | 3,001,469 |
| Last Close | $27.85 | $199.66 |
| 52 Week Range | $13.50 - $38.60 | $163.33 - $251.99 |
| % from 52W High | -27.85% | -20.77% |
| All-Time High | $163.08 (Sep 06, 2021) | $287.32 (Jul 24, 2023) |
| % from All-Time High | -82.92% | -30.51% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.55% | 0.10% |
| Quarterly Earnings Growth | -0.55% | 0.18% |
| Financial Health | ||
| Profit Margin (TTM) | -0.42% | 0.07% |
| Operating Margin (TTM) | -0.56% | 0.18% |
| Return on Equity (TTM) | -0.26% | 0.06% |
| Debt to Equity (MRQ) | 12.04 | 75.93 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $6.83 | $88.87 |
| Cash per Share (MRQ) | $3.83 | $2.64 |
| Operating Cash Flow (TTM) | $-28,525,000 | $3.25B |
| Levered Free Cash Flow (TTM) | $6.41M | $3.37B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 1.80% |
| Last 12-Month Dividend | N/A | $3.03 |
Valuation & Enterprise Metrics Analysis: Staar Surgical vs Becton, Dickinson
| Metric | STAA | BDX |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 49.73 | 35.89 |
| Forward P/E | 35.39 | 12.48 |
| PEG Ratio | -0.15 | 1.88 |
| Price to Sales (TTM) | 6.17 | 2.63 |
| Price to Book (MRQ) | 4.09 | 2.21 |
| Market Capitalization | ||
| Market Capitalization | $1.39B | $56.27B |
| Enterprise Value | $1.24B | $74.75B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 5.51 | 3.50 |
| Enterprise to EBITDA | -16.94 | 12.63 |
| Risk & Other Metrics | ||
| Beta | 0.62 | 0.22 |
| Book Value per Share (MRQ) | $6.83 | $88.87 |
Financial Statements Comparison: Staar Surgical vs Becton, Dickinson
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | STAA | BDX |
|---|---|---|
| Revenue/Sales | $42.59M | $5.27B |
| Cost of Goods Sold | $14.58M | $3.02B |
| Gross Profit | $28.01M | $2.26B |
| Research & Development | $13.66M | $302.00M |
| Operating Income (EBIT) | $-34.74M | $637.00M |
| EBITDA | $-11.15M | $1.21B |
| Pre-Tax Income | $-54.49M | $363.00M |
| Income Tax | $-275,000 | $55.00M |
| Net Income (Profit) | $-54.21M | $308.00M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | STAA | BDX |
|---|---|---|
| Cash & Equivalents | $173.11M | $667.00M |
| Total Current Assets | $326.50M | $8.67B |
| Total Current Liabilities | $68.36M | $7.69B |
| Long-Term Debt | $33.12M | $17.67B |
| Total Shareholders Equity | $349.97M | $25.24B |
| Retained Earnings | $-121.79M | $16.15B |
| Property, Plant & Equipment | $865,000 | N/A |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | STAA | BDX |
|---|---|---|
| Operating Cash Flow | $-15.68M | $941.00M |
| Capital Expenditures | $-1.47M | N/A |
| Free Cash Flow | $-7.20M | $35.00M |
| Debt Repayment | $-42,000 | $-1.00M |
| Common Stock Repurchase | $-1.28M | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | STAA | BDX |
|---|---|---|
| Shares Short | 6.45M | 5.48M |
| Short Ratio | 9.86 | 1.90 |
| Short % of Float | 0.29% | 0.02% |
| Average Daily Volume (10 Day) | 2,070,420 | 2,951,116 |
| Average Daily Volume (90 Day) | 2,461,810 | 3,001,469 |
| Shares Outstanding | 49.29M | 289.10M |
| Float Shares | 29.98M | 285.99M |
| % Held by Insiders | 0.01% | 0.01% |
| % Held by Institutions | 1.11% | 0.92% |
Dividend Analysis & Yield Comparison: Staar Surgical vs Becton, Dickinson
| Metric | STAA | BDX |
|---|---|---|
| Last 12-Month Dividend | N/A | $3.03 |
| Last 12-Month Dividend Yield | N/A | 1.80% |
| 3-Year Avg Annual Dividend | N/A | $3.16 |
| 3-Year Avg Dividend Yield | N/A | 0.40% |
| 3-Year Total Dividends | N/A | $9.48 |
| Ex-Dividend Date | N/A | Mar 10, 2025 |